Trial of Memantine for Cognitive Impairment in Multiple Sclerosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Multiple SclerosisCognition Disorders
Interventions
DRUG

Memantine

Trial Locations (4)

90033

USC, Los Angeles

97201

OHSU, Portland

98101

MS Hub, Seattle

75390-9036

UT Southwestern, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

collaborator

University of Southern California

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

MS-Hub Seattle

UNKNOWN

lead

Oregon Health and Science University

OTHER